Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update.
about
Critical care of patients with cancerBiosimilars in the management of neutropenia: focus on filgrastimLipegfilgrastim in the management of chemotherapy-induced neutropenia of cancer patientsThe effectiveness and safety of same-day versus next-day administration of long-acting granulocyte colony-stimulating factors for the prophylaxis of chemotherapy-induced neutropenia: a systematic reviewOptimal primary febrile neutropenia prophylaxis for patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer: a systematic review.Predicting neutropenia risk in patients with cancer using electronic data.Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma.Phase II randomized study of PM01183 versus topotecan in patients with platinum-resistant/refractory advanced ovarian cancerDevelopment and validation of a prognostic scoring model for Mycobacterium avium complex lung disease: an observational cohort study.Infection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma.Emerging agents for the prevention of treatment induced neutropenia in adult cancer patients.Efficacy and safety of acupuncture for chemotherapy-induced leucopoenia: protocol for a systematic review.Low Levels of NDRG1 in Nerve Tissue Are Predictive of Severe Paclitaxel-Induced Neuropathy.The Impact of the Duration of Adjuvant Chemotherapy on Survival in Patients with Epithelial Ovarian Cancer - A Retrospective Study.How I diagnose and treat neutropenia.Risk of chemotherapy-induced febrile neutropenia in cancer patients receiving pegfilgrastim prophylaxis: does timing of administration matter?Trajectory of absolute neutrophil counts in patients treated with pegfilgrastim on the day of chemotherapy versus the day after chemotherapy.Pathological complete response rate in hormone receptor-negative breast cancer treated with neoadjuvant FEC, followed by weekly paclitaxel administration: A retrospective study and review of the literatureReal-world adjuvant TAC or FEC-D for HER2-negative node-positive breast cancer in women less than 50 years of age.Factors Influencing Compliance to Radical Treatment of Middle Thoracic Esophageal Cancer: An Audit from a Regional Cancer Centre.Co-administration of dexamethasone increases severity and accelerates onset day of neutropenia in bladder cancer patients on methotrexate, vinblastine, adriamycin and cisplatin chemotherapy: a retrospective cohort study.Use of clozapine alongside chemotherapy in a treatment-resistant bipolar disorder patient with ovarian carcinoma: A case report and brief review.Impact of Guidance on the Prescription Patterns of G-CSFs for the Prevention of Febrile Neutropenia Following Anticancer Chemotherapy: A Population-Based Utilization Study in the Lazio Region.Pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in patients with solid tumors.Interpreting febrile neutropenia rates from randomized, controlled trials for consideration of primary prophylaxis in the real world: a systematic review and meta-analysis.Model-based prediction of myelosuppression and recovery based on frequent neutrophil monitoring.Risk of chemotherapy-induced neutropenic complications when treating patients with non-Hodgkin lymphoma.Multicenter Retrospective Analysis of Clinical Characteristics, Treatment Patterns and Outcomes in Very Elderly Patients with Diffuse Large B-cell Lymphoma: The Korean Cancer Study Group LY16-01.Optimizing Symptoms and Management of Febrile Neutropenia among Cancer Patients: Current Status and Future Directions.Tbo-Filgrastim: A Review in Neutropenic Conditions.Cost of Cancer-Related Neutropenia or Fever Hospitalizations, United States, 2012.Bending the Cost Curve in Childhood Cancer.The safety and efficacy of Onivyde (irinotecan liposome injection) for the treatment of metastatic pancreatic cancer following gemcitabine-based therapy.Supportive Care in Older Adults with Cancer: Across the Continuum.Procarbazine, Lomustine, and Vincristine (PCV) Regimen for Central Nervous System Tumors.CD114: A New Member of the Neural Crest-Derived Cancer Stem Cell Marker Family.Systemic Combination Chemotherapy in Elderly Pancreatic Cancer: a Review.Cost-effectiveness of febrile neutropenia prevention with primary versus secondary G-CSF prophylaxis for adjuvant chemotherapy in breast cancer: a systematic review.Impact of recommended weight-based dosing of granulocyte-colony stimulating factors in acute leukemia and stem cell transplant patients.Pentostatin, Cyclophosphamide and Rituximab (PCR) Regimen.
P2860
Q26746976-414F5A3D-10D7-4B82-A84D-4D0E56A94D5FQ26764906-4B49F35F-A032-4C47-A3A9-98FFC47AB75CQ26768126-2E38799F-9BF1-43E3-876A-66AD49E7CC0AQ29994513-A8C06852-EC72-484D-9712-F36BE33234FCQ30244077-9BDA0F47-D672-40AB-86F6-9DC6BA7475ABQ31131362-7CCBF9BF-6A52-4F87-97B9-74529967672CQ33441702-8ECD58ED-09DB-4926-9613-EDD11D47017BQ33749044-03852F9B-280D-45ED-BAA1-6B27F711F2D8Q33814448-4B6B437E-1708-4DDA-AD6A-6B0991C43405Q33861071-B97E2940-48C0-4C4F-8697-E40180820393Q36007020-29BE1B20-82EC-4D53-9C24-FA860F6674B1Q36031915-57B39FF7-F32D-435D-9404-CEE4A31942C5Q36157639-A1D7FCE8-07E9-4433-841B-477E596F3158Q36242803-0F348F34-4D8D-4893-A175-0E8662D1E69CQ36342838-9F6BFD90-CA71-484B-8CE4-429265235F9FQ36723903-B9473846-B9D9-4451-AA8A-2459C565D578Q36762853-5BC9FCC2-084C-427C-A9DF-A86DF6563D6CQ36825817-A9660086-E012-4773-883E-D2E3F0B6C611Q36989067-46EEA5E3-F2B2-4E6C-A14F-D54F701C3F01Q37151826-CFF612DD-D3F5-4160-8B4F-83EE915142D6Q37579007-DD2AB508-211E-4630-8660-B1E51CB5ABCBQ37609756-DD6B2BFD-9348-4069-9533-C7FD8BA9E3B8Q37737572-A9B67293-8F02-4C48-A9F2-B265B7EDBEB3Q38613025-924AC683-360B-42B5-8F56-D0B71952F170Q38682028-A8437F62-FF6F-4378-B889-CE8ECDD949ECQ38705873-2FB15FB5-8874-404A-8B4D-C19D92798B14Q38711166-ED28E323-30E8-477B-9A2C-AB7EB431259FQ38731955-177E4B22-B1FA-40D8-9062-70BE83FFF54EQ38749061-C8A99273-9CC0-4417-8E32-CB5E878D1402Q38792513-9765F2AD-5832-4C90-BC72-CF17CC2D7730Q38823135-00CD90EE-7FD9-472D-9CE2-BCA4FFD95B02Q38837762-67267390-66F3-4A24-A544-0918EA135ADEQ38843097-2FE2790B-1009-4B60-A1FB-C33E183EC8BBQ38876363-6ED44CB2-1279-49BF-8257-95D19B7A7788Q38892293-369925D5-93E6-4E2B-A478-16CBF208A0BCQ38900723-596915B2-BDB3-49F4-B57C-9CEDE0CF3BD4Q38902171-7ECB06D3-F659-4549-9F5E-5D79CE900944Q38940016-B9A66C40-76F0-40FB-91D5-6940ED2A62A6Q39000902-A3A400AB-71D3-43DA-A594-6C065374F527Q39037182-A07F9F33-4EB5-4136-A7D8-20D6CA9FFBF4
P2860
Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Recommendations for the Use of ...... cal Practice Guideline Update.
@ast
Recommendations for the Use of ...... cal Practice Guideline Update.
@en
Recommendations for the Use of ...... cal Practice Guideline Update.
@nl
type
label
Recommendations for the Use of ...... cal Practice Guideline Update.
@ast
Recommendations for the Use of ...... cal Practice Guideline Update.
@en
Recommendations for the Use of ...... cal Practice Guideline Update.
@nl
prefLabel
Recommendations for the Use of ...... cal Practice Guideline Update.
@ast
Recommendations for the Use of ...... cal Practice Guideline Update.
@en
Recommendations for the Use of ...... cal Practice Guideline Update.
@nl
P2093
P356
P1476
Recommendations for the Use of ...... cal Practice Guideline Update.
@en
P2093
Antoinette J Wozniak
Cheryl L Perkins
Gary H Lyman
George Somlo
James L Khatcheressian
James L Wade
Jeffrey Crawford
John M Goldberg
Kari Bohlke
Kenneth R Carson
P304
P356
10.1200/JCO.2015.62.3488
P407
P577
2015-07-13T00:00:00Z